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ABSTRACT  
Sepsis is a systemic inflammatory responseas a result of uncontrolled infections. 
Neutrophils are the first cells to reach the primary sites of infection and chemokinesplay a key 
role in recruiting neutrophils. However, in sepsis chemokines could also contribute to neutrophil 
infiltration to vital organs leading to multiple organ failure. ACKR2 is an atypical chemokine 
receptor, which can remove and degrade inflammatory CC chemokines. The role of ACK2 in 
sepsis is unknown. Using a model of cecal ligation and puncture (CLP), we demonstrate here 
that ACKR2 deficient (-/-) mice exhibited a significant reduction in the survival rate compared to 
similarly treated wild type (WT) mice. However, neutrophil migration to the peritoneal cavity 
and bacterial load were similar between WT and ACKR2-/- mice during CLP.  In contrast, 
ACKR2-/- mice showed increased neutrophil infiltration and elevated CC chemokine levels in the 
lung, kidney and heart compared to the WT mice. In addition,ACKR2-/-mice also showed more 
severelesions in the lung and kidney than those in the WT mice. Consistent with these results, 
WT mice under non-severe sepsis (90% survival) had higher expression of ACKR2 in these 
organs than mice under severe sepsis (no survival).  Finally, the lungs from septic patients 
showed increased number of ACKR2+ cellscompared to those of non-septic patients. Our data 
indicate that ACKR2 may have a protective role during sepsis, and the absence of ACKR2leads 
to exacerbated chemokine accumulation, neutrophil infiltration and damageto vital organs.  
KEYWORDS:Sepsis, atypical chemokine receptor,ACKR2, cecal ligation and puncture, CLP. 
 
Copyright © 2017 by the Shock Society. Unauthorized reproduction of this article is prohibited.
INTRODUCTION  
 
 Sepsis is life-threatening organ dysfunction causedby dysregulated host response to 
infection(1).The recruitment of neutrophils to an infected area counters the infection and avoids 
pathogen spreading to the circulation (2-4). However, the infiltration of neutrophils into vital 
organs contributes to organ dysfunction during sepsis and, consequently, to death. Both 
processesaremainly mediatedby signaling of the G protein-coupled receptor, including the 
chemokine receptors (5, 6).  
ACKR2 is an atypical chemokine receptor that does not signal via G protein because of a 
modification in the G protein-binding domain (DRYLAIV motif is altered to DKYLEIV) 
(7).However, ACKR2 bindswith high affinity to inflammatory chemokines from the CC 
subfamilyleading to receptor internalization and CC chemokines degradation(7-9), and 
contributes to the resolution of several inflammatory conditions(7, 10-13).However, the role of 
ACKR2 receptor in thepathophysiology of sepsis is hitherto unknown. 
In the present study, we hypothesized that ACKR2 could contribute to the degradation of 
chemokines in the foci of infection or in the vital organs, leading, in the first case, to aggravation 
of sepsis and, in the second case, to protection. To test these possibilities, we used ACKR2 
knockout (-/-) mice in a model of cecal ligation and puncture to induce different severities of 
sepsis.  
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MATERIALS AND METHODS  
 
Mice 
Experiments were performed on both male and female mice between 6 and 8 weeks old. 
C57BL/6 (wild-type, WT) mice were obtained from the animal facility of the University of São 
Paulo, São Paulo, Brazil.ACKR2-/-mice on the C57BL/6 background were generated and donated 
by Professor Sergio Lira (Icahn School of Medicine at Mount Sinai, United States)(10-11).The 
study was approved by the Ethics Committee for  the Use of Animals (CEUA) of RibeirãoPreto 
Medical School, University of Sao Paulo (protocol number 105/2014).The care and treatment of 
the animals were based on the Guide for the Care and Use of Laboratory Animals(14). 
Sepsis Model 
Cecal ligation and puncture (CLP) was usedto induce non-severe (NS-CLP) and severe 
sepsis (S-CLP). Briefly, the animals were anesthetized with ketamine and xylazine diluted in 
PBS (100 mg/kg ketamine and 10 mg/kg xylazine, UniãoQuimica, BR). The cecum of the 
animals was exposed, ligated, and punctured, according with the severity of sepsis (one puncture 
with 21G needle and one puncture with 18G needle to induce non-severe and severe sepsis, 
respectively). Next, the cecum was repositioned in the abdomen, and the peritoneal wall was 
closed. The animals received 1 mL of saline subcutaneously after this procedure to avoid 
dehydration. Sham-operated mice were under laparotomy without CLP. The group of animals 
treated with antibiotic received an intraperitoneal injection of ertapenem sodium (20 mg/kg, 
Merck Research Laboratory, WhitehouseStation, NJ) beginning 6 h after CLP and thenevery 12 
h up to day 3.The survival of mice was recordedevery 12 h for 10 days. Mice showing signs of 
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ataxia, tremor and/or agonal breathing wereeuthanized by overdose of ketamine/xylazine 
followed by cervical dislocation. At the end of 10 days,surviving mice were euthanized. Some 
mice were also euthanizedat different time points after CLP for biochemical and cell migration 
analysis. It should be noted that the phenotype of ACKR2-/- mice could be variable in this sepsis 
model. However, when the mice were treated with antibiotics, the ACKR2-/- mice remained 
consistently more susceptible to CLP.Thus the variability observed was most likely due a change 
of microbiota in the mice over the years in a conventional SPF environment. 
In vivo determination of Neutrophil Migration 
Neutrophil migration was determined 24 and 36 h after CLP as described previously (15). 
Briefly, the animals were euthanized and the peritoneal cavity was washed with 1.5 mL of PBS 
containing 1 mM EDTA. Total cell counts from the lavage were performed with a cell counter 
(Coulter AC T series analyzer, Coulter Corp., Miami, USA), and differential cell counts were 
carried out on cyto-centrifuge slides (Cytospin 3, Shandon Southern Products, Astmoore, UK) 
and stained by the May-Grünwald-Giemsa (Rosenfeld) method. 
Bacterial counts 
Bacterial counts were determined 24 and 36 h after CLP as previously described (16). 
Briefly, mice were euthanized and peritoneal lavage fluid and blood were harvested, diluted 
serially with sterile PBS, plated on Muller-Hinton agar dishes (Difco Laboratories, Detroit, 
USA) and incubated at 37°C for 18 h and colony-forming units (CFU) were visually counted. 
Chemokine assay  
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Theconcentrations of chemokines in the lungs, kidneys and heartwere measured 24 h 
after CLP and in the peritoneal lavage 24 and 36 h after CLP.  The lung, kidney and heart tissues 
were homogenized and the concentration of chemokine in the supernatant wasdeterminedby 
ELISA kits (R&D Systems), as previously described (17). 
Myeloperoxidase activity assay 
Tissue myeloperoxidase (MPO) activity was used as a biochemical index of neutrophil 
infiltration into the lung, kidney and heart, aspreviously described(18). 
Assessment of lung resistance 
Mice were anesthetized with a subcutaneous injection of ketamine and xylazine (130 
mg/kg ketamine and 8.5 mg/kg xylazine) to maintain spontaneous breathing under anesthesia. 
Mice were tracheostomized, placed in a body plethysmograph and connected to a computer-
controlled ventilator (Forced Pulmonary Maneuver System, Buxco Research Systems, 
Wilmington, North Carolina USA). This laboratory set-up, specifically designed for mice, has 
only a canula volume (death space) of 0.8 mL and provides semi-automatically three different 
maneuvers: Boyle’s Law FRC, quasi-static pressure-volume and fast-flow volume maneuver. 
First, an average breathing frequency of 160 breaths/min was imposed to the anesthetized animal 
by pressure-controlled ventilation until a regular breathing pattern and complete expiration at 
each breathing cycle was obtained. Under mechanical respiration the Lung Resistance (Rl) was 
determined as previously described(19).  
Blood urea nitrogen (BUN) assays  
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Animals were euthanized 24 h after CLP and blood was collected to measure renal 
dysfunction assessed by BUN levels. The assays were performedaccording to the specification of 
a commercial kit (Labtest, Brazil). 
Real Time q-PCR  
 Lung, kidney and heart were collected in trizol® (Sigma) 12 or 24 h after CLP and 
macerated for extraction of total RNA. After extraction, an aliquot of 1μL was used to determine 
the RNA concentration by reading in NanoDrop (Thermo Fisher Scientific) and 1 μg of the 
extracted RNA was used for the cDNA conversion using the High-Capacity cDNA Reverse 
transcription kit (Life Technologies) in a thermal cycler. The cDNA was used for the 
quantification of the Ccbp2 (ACKR2) gene expression (TaqMan® Assay: Mm00445551_m1) by 
real-time PCR using TaqMan® Universal Master Mix II, at the UNG, according to the 
manufacturer's instruction  (Life Technologies). Gapdhgene (TaqMan® Assay: Gapdh-
Mm99999915_g1)was used as a control for normalization of expression levels. The real-time 
quantitative reaction was performed in the Viia ™ 7 Real-Time PCR System (Applied 
Biosystems). The results were analyzed using the 2-ΔΔCT method and are expressed in relation 
to the reference group (sham). 
Patient samples 
Lung samples from patients who died from sepsis (n = 11) and controls  (n = 11, 
individuals who died from other causes), that werestored in paraffin blocks (at the 
ClinicalHospital, Department of Pathology, Ribeirao Preto Medical School)were used in this 
study.In addition, sample from 4 patients with Chronic Obstructive Pulmonary Disease (COPD) 
were used as control for the antibody. The median of the age of the individuals included in the 
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study was 36 for the septic patients and 38 for the control patients. 27% and 54% of the controls 
and septic patients, respectively, were female.The procedures performed with these samples were 
approved by the Committee of Ethics in Research with Human Subjects (CEP), Certificate of 
Presentation for Ethical Assessment (CAAE) 54775416.5.0000.5440 and official approval 
number 1579/2016. 
Immunohistochemistry for ACKR2 
 After deparaffinizationand hydration, the slides (5 µm)were incubated for 30 min in 0.5% 
H2O2 diluted in methanol. The slides were then washed in TBST/Tween (0.05%) for further 
incubation in 0.01M citrate buffer (pH = 6.0) for 5 min at 100° C. After washing in 
TBST/Tween, the sections were incubated with Fc block for 30 min and in 2.5% horse serum for 
a further 30 min. The slides were then labeled with anti-ACKR2 polyclonal rabbit antibody 
(Sigma)overnight, at 4° C. The slides were then washed and incubated with an anti-rabbit 
secondary antibody (Vector Labs, Peterborough, UK) for 1 h at room temperature. After 
washing, peroxidase-conjugated streptavidin (Vector Labs, Peterborough, UK; 30 minutes, room 
temperature)was added andthe slides were incubated with DAB for 2 min. After hydration, the 
slides were stained with hematoxylin and assembled with mounting medium. ACKR2 expression 
analyzes were performed at 400X magnification, and 20 fields were evaluated per slide. The 
number of positive cells for ACKR2+ cellswas counted visually and the results are expressed as 
mean number of ACKR2 positive cells per field. 
 
Statistical analyzes 
The statistical analyzes were performed using GraphPad Prism. Survival rates were 
analyzed by Mantel-Cox log-rank test. Bacterial counts are expressed as medians and 
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allothermouse data are expressed as box-and-whiskers (Min to Max). The human data are 
expressed as dot-plot and mean. The human data were analyzed by t-test and all the others by 
ANOVA followed by Bonferroni. 
RESULTS  
ACKR2-deficient mice are more susceptible to CLP-induced sepsis 
To investigate the potential role of ACKR2 in the pathogenesis of sepsis, we 
firstcompared the survival rate of WT and ACKR2-/- mice underdifferent severities of CLP-
induced sepsis. In the severe model of CLP (S-CLP), all mice died within 3 days after CLP and 
there was no difference in the survival rate between the WT and ACKR2-/- mice. However, in the 
non-severe modelof sepsis (NS-CLP), ACKR2-/- mice were significantly more susceptible than 
the WT mice (survival rate: 88% in WT animals versus 33% in the ACKR2-/- group) (Fig. 1A). 
These results indicate that ACKR2 plays a significant role in protecting mice against sepsis.  
We have previously shownthat neutrophil migration to the primary site of infection 
(peritoneal cavity) during CLP is crucial for preventing the spreading of microorganisms to the 
circulation and thusavoidingthe aggravation of sepsis(15, 20). We therefore determined 
neutrophil migration and the bacterial load in the peritoneal cavity and in the blood.Surprisingly, 
there was no significant difference in the number of neutrophils in the peritoneal cavity between 
the WT and ACKR2-/-mice under the NS-CLP (Fig. 1B).  Consistent with this observation, the 
level of chemokines(CXCL2,CCL2, CCL3 and CCL5) in the peritoneal cavity was also similar 
in WT and ACKR2-/- mice after NS-CLP(Figs. 1C-F). In addition, the bacterial loads in the 
peritoneal cavity (Fig. 1G) and in the circulation (Fig. 1H) were also similar between WT and 
ACKR2-/- animals. These results indicate that the increased severity of the ACKR2-/- mice was 
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likely to be due to factors other than thereduction of neutrophil migration and bacterial load in 
the peritoneal cavity. 
ACKR2 controls chemokines accumulation and neutrophil infiltration in secondary organs 
during sepsis 
We and others have shown that CC chemokines are increased in secondary organs and 
induce neutrophil accumulationafter sepsis induction (21). We therefore investigated the possible 
role of ACKR2 in the control of the systemic inflammatory response. Lung, kidney and heart 
were collected 24 h afterNS-CLP and the concentrations of chemokine in the tissue homogenates 
were determined by ELISA. There was a significant increase in the level of CCL3 in the lung 
(Fig. 2A), CCL5 in the kidney (Fig. 2B) and CCL2 (Fig. 2C) and CCL3 (Fig. 2D) in the heartof 
ACKR2-/- mice compared to those of the WT mice.   
 Consistent with this observation, the number of neutrophils was also 
significantlyincreased in the lung, kidney and heart of the ACKR2-/- mice compared to those of 
the WT mice (Fig. 3A-C). The increase in the number of neutrophilswould be expected to lead to 
exacerbated organ damage. This is shownby a significant increase in theblood urea nitrogen 
(BUN, a measurement of kidney damage) levels(Fig. 3D) and by a tendency to increase in the 
lung resistance(Fig. 3E)in the ACKR2-/- mice compared to those of the WT mice under NS-CLP. 
Ackr2 mRNA is induced in vital organs after sepsis 
  We then investigated whether the expression of ACKR2 is affected by sepsis induction. 
WT mice were given either non-severe sepsis (NS-CLP) or severe sepsis (S-CLP) and their 
organs harvested 12 or24 h after CLP. Ackr2 mRNA levels in the lung12 h (Fig. 4A) and 24 h 
(Fig. 4B) after CLP, kidney 24 h after CLP (Fig. 4C) and heart 24 h after CLP(Fig. 4D) were 
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significantly increased in the mice with NS-CLP compared to those of the control sham-operated 
mice. In contrast, although Ackr2 expression was also increased in the lungs of mice under S-
CLP 12 h after surgery, its expressionreturned to the level of the control mice by 24 h. In 
addition, the levels of ACKR2 mRNA in thekidney and heartof the micewith S-CLP were also 
not significantly different from those of the control mice 24 h after sepsis induction. These 
results indicate that the sustained higher level of Ackr2mRNA expressionis correlated with 
increasedlevel of survival of septic mice, and hence support the notion that ACKR2 are 
protective against sepsis through its elevated levels in the vital organs.  
The effect of antibiotics on the sepsis in ACKR2-/- mice 
To confirm that the protective role of ACKR2 during sepsis is due to the participation of 
this receptor in the systemic inflammatory response, rather than in the control of the local 
response against the infection, we next used a lethal sepsis model (S-CLP), which induces an 
exacerbated inflammatory response, and then treat the animals with antibiotics to controlthe 
infection. Treatment of mice under S-CLP with antibiotics significantly reduced bacteremia 
andimprovedthe survival of WT animals, as shown previously(22). While none of the WTmice 
survived past day 2 of S-CLP (without antibiotic), 40% of WT mice treated with the antibiotic 
survivedS-CLP. In contrast, all the ACKR2-/- mice died from S-CLP by day 2.5whether treated 
or not with antibiotics (Fig. 5A). Additionally, the ACKR2-/- mice showed higher levels of 
myeloperoxidase (MPO) in the lung,kidney and heart than those of the WT mice following S-
CLP and antibiotic treatment (Fig. 5B-D). These results therefore confirm that the higher 
mortality rate in the ACKR2-/- mice was not due to local infection. Instead, the high 
susceptibility of the ACKR2-/- mice was likely to be due to inflammatory response in the vital 
organs. 
Copyright © 2017 by the Shock Society. Unauthorized reproduction of this article is prohibited.
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ACKR2 expression in patients with sepsis 
 Finally, we investigated whether the expression ofACKR2is also altered in the lungs of 
patients with sepsis. We stained for ACKR2 positive cells in the lung tissues of 11 patients with 
sepsis and 11 control samples from non-septic patients. The analysis of the expression of 
ACKR2+ cells in the lung of septic patients showed clear and markedly elevated number of 
ACKR2+cells in comparison with control patients (Fig. 6A-C).As positive control for the 
antibody used,we also stained ACKR2 in patients with Chronic Obstructive Pulmonary Disease 
(COPD) (Fig. 6D). Morphological analysis indicates that the ACKR2+ cells are macrophage-like 
cells. These results are consistent with the elevated levels of Ackr2 mRNA expression in the 
lungs of mice during the early stage of severe sepsis (Fig. 4A). 
Discussion 
Data reported here demonstrate a hitherto unrecognized protective role of the atypical 
chemokine receptor, ACKR2, in sepsis. ACKR2 is induced during sepsis and it attenuates the 
damage to the vital organs caused by sepsis, most likely by reducing the level of local CC 
chemokines, which are potent mediators in recruiting activated neutrophils to these organs and 
hence causing damage to the organs. Interestingly, ACKR2 had little or no effect on the levels of 
chemokines and the number of neutrophils in the primary foci of infection (peritoneal cavity). 
Consequently, ACKR2 also had no effect on the bacterial load in the peritoneal cavity or in the 
peripheral blood.  
 The dichotomy effect of ACKR2 seen here is consistent with the emerging concept 
separating the control of bacteremia from limiting inflammatory organ damage in the 
management of sepsis (23). Resistance to pathogens does not always confer protection from 
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multiple organ damage (24). This is clearly borne out in our study showing that the control of 
bacterial load by antibiotics did not rescue the ACKR2-/- mice from multiple organ damage 
caused by the high level of chemokines and neutrophil infiltration in the lung, kidney and heart. 
This observation is also consistent with a recent observation thattreatment of mice under CLP-
induced sepsis with anthracycline, a compound used for the treatment of cancer, improved the 
survival of mice by increasing autophagy and reducing lung injury without affecting the bacterial 
load, suggesting that anthracycline treatment protected the organ damage during sepsis (25).In 
addition, animals deficient in the enzyme hemeoxygenase are more susceptible to sepsis, due to 
increased organ damage with no change in the pathogen load(26). 
  The levels of systemic cytokines and chemokines vary with the severity of the disease 
during sepsis.  Clinically, the levels of CCL2 and CCL3 are elevated systemically during severe 
sepsis or septic shock compared with non-severe sepsis (27). One possible explanation is that 
during severe sepsis the further spread of the pathogens into the bloodstream leads to increased 
activation of the host cells, culminating in the increased production of the inflammatory 
mediators.Our data showing that ACKR2 expression is increased in the lungs, kidney and heart 
of WT mice after the induction of non-severe sepsis, but not in severe sepsis offers an alternative 
mechanism. Thus, the higher tissue levels of inflammatory CC chemokines during severe sepsis 
could be also due to the failure to remove and degradate these chemokines by the reduced levels 
of ACKR2 in these organs. In psoriasis, it was demonstrated that ACKR2 expression is increased 
in uninvolved skin regions of patients. However, the expression of ACKR2 is reduced or absent 
in damaged regions. Associated with this, the skin inflammation is increased in regions with 
injuries, or in areaswith low ACKR2 expression(28). In addition, transgenic expression of 
ACKR2 in keratinocytes prevented the growth of skin tumors in mice by the reduction of skin 
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inflammation (12). However, the mechanism by which ACKR2 is modulated during sepsis and 
in these other pathologies is currently unknown and warrants further investigation.  
  Our clinical data showing that the lungs ofseptic patients had increased frequency of 
ACKR2+ cellsmay at first seem counter intuitive. However, our data from murine sepsis show 
that both severe and non severe septic mice exhibited elevated Ackr2 mRNA at 12 h time point 
suggest that the observed increased frequency of ACKR2+ cells in the lungs of the sepsis patients 
is not inconsistent with a role of ACKR2 in clinical sepsis. Thus, the observed elevated levels of 
ACKR2 in the patients who succumbed to sepsis may represent a failed-attempt by these patients 
to control the disease. However, this hypothesis is ethically untestable.In corroboration, alveolar 
macrophages from patients with chronic COPD also express ACKR2 and may, in same way, 
controls the acute lung injury during this disease (29). 
 Sepsis is a complex condition likely involved the interplay of multiple regulatory factors 
and mediators. Our finding that ACKR2 plays a substantive protective role reducing remote 
organ injury in sepsis suggests that ACKR2 may be a potential therapeutic agent in this 
important and clinically unmet condition. 
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FIGURE LEGENDS 
Figure 1. ACKR2-/- mice are more susceptible to CLP-induced sepsis. WT and ACKR2-/- 
miceunderwent sham, non-severe (NS-CLP) or severe(S-CLP) sepsis surgery. (A) Survival of 
mice with CLP-induced sepsis. Results are% of survival, analyzed by Mantel-Cox log-rank test, 
n=6-9 animals/group,from 3-5 experiments. This graph is representative of one experiment. * p< 
0.05. (B) Neutrophil migration to the peritoneal cavity.The levels of CXCL2 (C), CCL2 (D), 
CCL3 (E) and CCL5 (F) were measured in theperitoneal exudate. The results are whiskers (min 
to max),n=6-8 animals/group. (G) Colony-forming units (CFU) in peritoneal exudates and (H) in 
blood. Horizontal bars are median values, each symbol represents individual mouse.  
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Figure 2. CC chemokine levels are increased in secondary organs of ACKR2-/- mice after 
CLP. WT and ACKR2-/- mice underwent sham or non-severe CLP and the level of CCL3 in the 
lung (A), CCL5 in the kidney (B), and CCL2 (C) and CCL3 (D)in the heart were measured. The 
results are whiskers (min to max), and were analyzed by ANOVA followed by Bonferroni,n=4-6 
animals/group,*p < 0.05.Data are representative of 2 experiments. 
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Figure 3. ACKR2-/- mice have increased neutrophils and lesion in peripheral organs after 
CLP. WT and ACKR2-/-mice underwent sham orNS-CLP. The neutrophil infiltration in the lung 
(A), kidney (B) and heart(C) were measured by myeloperoxidase activity (MPO). (D) BUN 
(blood urea nitrogen)and (E) Lung resistance were measured 24 h after CLP. The results 
arewhiskers (min to max), and were analyzed by ANOVA followed by Bonferroni, n=5-7,*p < 
0.05. Data are representative of 2experiments (A-C, E). 
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Figure 4. ACKR2is increasedin peripheral organs after CLP. WT mice underwent sham,NS-
CLPorS-CLP. ACKR2 mRNA at 12 h (A) and 24 h (B) in the lungs, kidney at 24 h (C) and heart 
at 24 h (D) were analyzed by Real Time qPCR. The results arewhiskers (min to max), and were 
analyzed by ANOVA followed by Bonferroni, n=5-6 animals/group,* p < 0.05. Data are 
representative of 2 experiments. 
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Figure 5. ACKR2 controls systemic inflammation during sepsis. WT and ACKR2-/- mice 
underwent sham or severe sepsis (S-CLP).  Some of the mice were treated with antibiotics (WT 
+ ANT and ACKR2-/- + ANT) after S-CLP.(A)Survival of mice, n=6-8 animals/group, 
*P<0.05.Neutrophils in the lung (B), kidney (C) and heart (D) were determined 24 h after CLP, 
by myeloperoxidase activity (MPO). The results arewhiskers (min to max), and were analyzed 
by ANOVA followed by Bonferroni, n=8,*p < 0.05. 
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Figure 6. ACKR2expression is increased in the lung of septic patients. Lung tissues of 11 
patients with sepsis and 11 control samples from non-septic patientswere stained with anti-
ACKR2 antibody for immunohistochemistry. (A-B) Representative images of ACKR2 
expression in control (A) and in septic patients(B) are shown. Arrows indicate ACKR2 positive 
cells.  (C) Number of ACKR2 positive cells per field in the lung of control and septic patients. 
Twenty fields were analyzed per slide. *P<0.05 by Student’s t test.(D) Representative image of 
ACKR2 expression inpatient with Chronic Obstructive Pulmonary Disease (COPD). Arrows 
indicate ACKR2 positive cells. 
 
 
